APRESOLINE 20mg powder for injection ampoule

Amdipharm Mercury Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0a3a873b3cdd7cb9
Product Name: APRESOLINE 20mg powder for injection ampoule
Artg Id: 43190
Artg Name: APRESOLINE hydralazine hydrochloride 20mg powder for injection ampoule
Sponsor: Amdipharm Mercury Australia Pty Ltd
Company Detail Path: /organization/amdipharm-mercury-australia-pty-ltd
Artg Date: 1993-02-15
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-CMI-01015-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2016-PI-01014-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

0a3a873b3cdd7cb9

Type

Standard